Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in Ocular Myasthenia
NCT00995722Phase 3Terminated
- Start
- Dec 2011
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of prednisone in myasthenia gravis (MG). Started Dec 2011; status: terminated.
02
Drugs
prednisone
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT00995722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995722.